Lactose (India) Ltd

The 50-day moving average for Lactose (India) Ltd has crossed above the 200-day moving average, signalling a golden cross on 19 Jun 2026. Yet, the stock declined 1.87% on the day this technical event occurred, while monthly momentum indicators remain bearish. This juxtaposition of signals calls for a detailed examination of the broader technical and fundamental context.

Lactose (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Lactose (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 May 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Lactose (India) Ltd has witnessed an upgrade in its quality grading from below average to average, reflecting notable improvements in key business fundamentals such as return on equity (ROE) and return on capital employed (ROCE). Despite this positive shift, certain financial metrics and market dynamics present a mixed picture for investors navigating the pharmaceuticals and biotechnology sector.

Lactose (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Lactose (India) Ltd has demonstrated a marked turnaround in its financial performance for the quarter ending March 2026, shifting from a flat to a positive financial trend. The pharmaceuticals and biotechnology micro-cap company posted its highest quarterly net sales in recent history, alongside significant profit growth, signalling a potential inflection point for investors amid a challenging sector backdrop.

Lactose (India) Limited, a Vadodara-based pharmaceutical and dairy products manufacturer, reported a robust 64.82% year-on-year revenue growth in Q4 FY26, with net sales reaching ₹45.77 crores compared to ₹27.77 crores in the corresponding quarter last year. However, net profit of ₹1.88 crores, whilst representing a 193.75% YoY improvement, reflected sequential volatility and margin compression that raises questions about the sustainability of the company's profitability trajectory.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 18 April 2026, providing investors with the latest perspective on the company’s position.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

For the third consecutive session, Lactose (India) Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 76.01 on 27 Mar 2026. This marks a significant 44.4% drop from its 52-week high of Rs 136.7, underscoring persistent selling pressure amid a broader market downturn.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

For the third consecutive session, Lactose (India) Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 80 on 23 Mar 2026. This marks a 12.97% drop over the last three days, underscoring persistent selling pressure amid broader market weakness.

For the second consecutive session, Lactose (India) Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 83.5 on 20 Mar 2026. This drop comes amid a broader market that is showing modest gains, highlighting a stark divergence for this pharmaceuticals micro-cap.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.